Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Sander

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Oncoimmunology|February 6, 2018
Virus-like particle display of HER2 induces potent anti-cancer responsesArianna Palladini, Susan Thrane, Christoph M Janitzek, et al.
Cells|August 31, 2019
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria ProteinSara R Bang-Christensen, Rasmus S Pedersen, Marina A Pereira, et al.
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.
Molecular Ecology Resources|June 8, 2018
Debugging diversity - a pan-continental exploration of the potential of terrestrial blood-feeding leeches as a vertebrate monitoring toolIda Baerholm Schnell, Kristine Bohmann, Sebastian E Schultze, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Mbio|October 12, 2021
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 VariantsLinda van Oosten, Jort J Altenburg, Cyrielle Fougeroux, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature Communications|January 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activityCyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Oncoimmunology|February 6, 2018
Virus-like particle display of HER2 induces potent anti-cancer responsesArianna Palladini, Susan Thrane, Christoph M Janitzek, et al.
Cells|August 31, 2019
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria ProteinSara R Bang-Christensen, Rasmus S Pedersen, Marina A Pereira, et al.
NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.
Molecular Ecology Resources|June 8, 2018
Debugging diversity - a pan-continental exploration of the potential of terrestrial blood-feeding leeches as a vertebrate monitoring toolIda Baerholm Schnell, Kristine Bohmann, Sebastian E Schultze, et al.
Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.
Mbio|October 12, 2021
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 VariantsLinda van Oosten, Jort J Altenburg, Cyrielle Fougeroux, et al.
Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.
Nature Communications|January 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activityCyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.
Pageof 6